Antiretroviral therapy adherence in a sample of men with low socioeconomic status: The role of task-specific treatment self-efficacy

References

• Ammassari, A., Trotta, M. P., Murri, R., Castelli, F., Narciso, P., Noto, P., … Antinori, A. (2002). Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature. Journal of Acquired Immune Deficiency Syndromes, 31, S123–S127.10.1097/00126334-200212153-00007
   PubMed Web of Science ®Google Scholar
• Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Englewood Cliffs, NJ: Prentice-Hall.
   Google Scholar
• Bandura, A. (1997). Self-efficacy: The exercise of control. New York, NY: Freeman.
   Google Scholar
• Brekke, M., Hjortdahl, P., & Kvien, T. K. (2003). Changes in self-efficacy and health status over 5 years: A longitudinal observational study of 306 patients with rheumatoid arthritis. Arthritis & Rheumatology, 49, 342–348.
   PubMed Web of Science ®Google Scholar
• Brown, J. L., Littlewood, R. A., & Vanable, P. A. (2013). Social-cognitive correlates of antiretroviral therapy adherence among HIV-infected individuals receiving infectious disease care in a medium-sized northeastern US city. AIDS Care, 25, 1149–1158.10.1080/09540121.2012.752566
   PubMed Web of Science ®Google Scholar
• Cargill, V. A. (2013). Linkage, engagement, and retention in HIV care among vulnerable populations: “I’m sick and tired of being sick and tired”. Topics in Antiviral Medicine, 21, 133–137.
   PubMedGoogle Scholar
• Cargill, V. A., Stone, V. E., & Robinson, M. R. (2004). HIV treatment in African Americans: Challenges and opportunities. Journal of Black Psychology, 30, 24–39.10.1177/0095798403259243
   Google Scholar
• Catz, S. L., Kelly, J. A., Bogart, L. M., Benotsch, E. G., & McAuliffe, T. L. (2000). Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychology, 19, 124–133.10.1037/0278-6133.19.2.124
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. (2013). HIV in the United States at a glance. Retrieved July 22, 2013, from www.cdc.gov/hiv/resources/factsheets/PDF/HIV_at_a_glance.pdf
   Google Scholar
• Chesney, M. A. (2006). The elusive gold standard. Future perspectives for HIV adherence assessment and intervention. Journal of Acquired Immune Deficiency Syndromes, 43, S149–S155.10.1097/01.qai.0000243112.91293.26
   PubMed Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Neidig, J., Zwickl, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTC adherence instruments. AIDS Care, 12, 255–266.10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• de Bruin, M., Viechtbauer, W., Schaalma, H. P., Kok, G., Abraham, C., & Hospers, H. J. (2010). Standard care impact on effects of highly active antiretroviral therapy adherence interventions: A meta-analysis of randomized controlled trials. Archives of Internal, 170, 240–250.10.1001/archinternmed.2009.536
   PubMed Web of Science ®Google Scholar
• Dima, A. L., Schweitzer, A.-M., Diaconiţǎ, R., Remor, E., & Wanless, R. S. (2013). Adherence to ARV medication in Romanian young adults: Self-reported behaviour and psychological barriers. Psychology, Health & Medicine, 18, 343–354.
   PubMed Web of Science ®Google Scholar
• Fox, M. P., McCoy, K., Larson, B. A., Rosen, S., Bii, M., Sigei, C., … Simon, J. L. (2010). Improvements in physical wellbeing over the first two years on antiretroviral therapy in Western Kenya. AIDS Care, 22, 137–145.10.1080/09540120903038366
   PubMed Web of Science ®Google Scholar
• Fox, M. P., & Rosen, S. (2010). Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007–2009: Systematic review. Tropical Medicine & International Health, 15(s1), 1–15.
   PubMedGoogle Scholar
• Gifford, A. L., Lorig, K., Chesney, M., Laurent, D., & Gonzalez, V. (1996). Patient education to improve health-related quality of life in HIV/AIDS: A pilot study. 11th International Conference on AIDS, Vancouver, British Columbia, Canada.
   Google Scholar
• Houston, E. (2009). Mapping mental representations of health behaviors: Idiosyncratic meanings and treatment outcomes. Paper presented at Cornell University, Department of Psychiatry Grand Rounds, New York-Presbyterian Hospital–Weill Cornell Medical Center, New York, NY.
   Google Scholar
• Houston, E., McKirnan, D., Cervone, D., Johnson, M. S., & Sandfort, T. G. M. (2011). Assessing treatment motivation among patients receiving antiretroviral therapy: A multidimensional approach. Psychology and Health, 27, 674–687. PMCID: PMC3306482.
   PubMed Web of Science ®Google Scholar
• Marc, L. G., Testa, M. A., Walker, A. M., Robbins, G. K., Shafer, R. W., Anderson, N. B., … Berkman, L.F., for the ACTG Data Analysis Concept Sheet Study Team. (2007). Educational attainment and response to HAART during initial therapy for HIV-1 infection. Journal of Psychosomatic Research, 63, 207–216.10.1016/j.jpsychores.2007.04.009
   PubMed Web of Science ®Google Scholar
• McDowell, I., & Newell, C. (1996). Measuring health: A guide to rating scales and questionnaires (2nd ed.). New York, NY: Oxford University Press.
   Google Scholar
• Millett, G. (2013). Disparities in HIV treatment engagement, adherence, and outcomes. Presentation at the 8th annual meeting of the International Conference on HIV Treatment and Prevention Adherence, Miami, FL. Retrieved from http://www.iapac.org/AdherenceConference/presentations/ADH8_Plenary_Millett.pdf
   Google Scholar
• Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., … Cooper, C. (2006). Adherence to HAART: A systematic review of developed and developing nation patient reported barriers and facilitators. PLOS Medicine, 3, 2039–2064.
   Web of Science ®Google Scholar
• Mugavero, M. J., Amico, K., Westfall, A. O., Crane, H. M., Zinski, A., Willig, J. H., … Saag, M. S. (2012). Early retention in HIV care and viral load suppression: Implications for a test and treat approach to HIV prevention. JAIDS Journal of Acquired Immune Deficiency Syndromes, 59, 86–93.10.1097/QAI.0b013e318236f7d2
   PubMed Web of Science ®Google Scholar
• Muñoz, M., Finnegan, K., Zeladita, J., Caldas, A., Sanchez, E., Callacna, M., … Shin, S. (2010). Community-based DOT-HAART accompaniment in an urban resource-poor setting. AIDS and Behavior, 14, 721–730.
   PubMed Web of Science ®Google Scholar
• Noel, E., Esperance, M., Mclaughlin, M., Bertrand, R., Devieux, J., Severe, P., … Koenig, S. P. (2013). Attrition from HIV testing to antiretroviral therapy initiation among patients newly diagnosed with HIV in Haiti. JAIDS Journal of Acquired Immune Deficiency Syndromes, 62, e61–e69.10.1097/QAI.0b013e318281e772
   PubMedGoogle Scholar
• Nokes, K., Johnson, M. O., Webel, A., Rose, C. D., Phillips, J. C., Sullivan, K., … Holzemer, W. L. (2012). Focus on increasing treatment self-efficacy to improve human immunodeficiency virus treatment adherence. Journal of Nursing Scholarship, 44, 403–410.10.1111/j.1547-5069.2012.01476.x
   PubMed Web of Science ®Google Scholar
• Pandya, R., Metz, L., & Patten, S. B. (2005). Predictive value of the CES-D in detecting depression among candidates for disease-modifying multiple sclerosis treatment. Psychosomatics, 46, 131–134.10.1176/appi.psy.46.2.131
   PubMed Web of Science ®Google Scholar
• Polisset, J., Ametonou, F., Arrive, E., Aho, A., & Perez, F. (2009). Correlates of adherence to antiretroviral therapy in HIV-infected children in Lomé, Togo, West Africa. AIDS and Behavior, 13, 23–32.10.1007/s10461-008-9437-6
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.10.1177/014662167700100306
   Web of Science ®Google Scholar
• Reif, S., Proeschold-Bell, R. J., Yao, J., LeGrand, S., Uehara, A., Asiimwe, E., & Quinlivan, E. B. (2013). Three types of self-efficacy associated with medication adherence in patients with co-occurring HIV and substance use disorders, but only when mood disorders are present. Journal of Multidisciplinary Healthcare, 6, 229–237.
   PubMedGoogle Scholar
• Reynolds, N. R., Testa, M. A., Marc, L. G., Chesney, M. A., Neidig, J. L., Smith, S. R., … Robbins, G. (2004). Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS and Behavior, 8, 141–150.10.1023/B:AIBE.0000030245.52406.bb
   PubMed Web of Science ®Google Scholar
• Rosen, S., Fox, M. P., & Gill, C. J. (2007). Patient retention in antiretroviral therapy programs in sub-Saharan Africa: A systematic review. PLoS Medicine, 4, e298.10.1371/journal.pmed.0040298
   PubMed Web of Science ®Google Scholar
• Schilder, A. J., Kennedy, C., Goldstone, I. L., Ogden, R. D., Hogg, R. S., & O’Shaughnessy, M. V. (2001). Being dealt with as a whole person. Care seeking and adherence: The benefits of culturally competent care. Social Science & Medicine, 52, 1643–1659.10.1016/S0277-9536(00)00274-4
   PubMed Web of Science ®Google Scholar
• Sethi, A. K., Celentano, D. D., Gange, S. J., Moore, R. D., & Gallant, J. E. (2003). Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clinical Infectious Diseases, 37, 1112–1118.10.1086/378301
   PubMed Web of Science ®Google Scholar
• Shively, M., Smith, T. L., Bormann, J., & Gifford, A. L. (2002). Evaluating self-efficacy for HIV disease management skills. AIDS and Behavior, 6, 371–379.10.1023/A:1021156914683
   Google Scholar
• Siegel, K., Karus, D., & Schrimshaw, E. W. (2000). Racial differences in attitudes toward protease inhibitors among older HIV-infected men. AIDS Care, 12, 423–434.10.1080/09540120050123828
   PubMed Web of Science ®Google Scholar
• Simoni, J. M., Huh, D., Wilson, I. B., Shen, J., Goggin, K., Reynolds, N. R., … Liu, H. (2012). Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 study. Journal of Acquired Immune Deficiency Syndromes, 60, 466–472.10.1097/QAI.0b013e31825db0bd
   PubMed Web of Science ®Google Scholar
• Steele, C. B., Meléndez-Morales, L., Campoluci, R., DeLuca, N., & Dean, H. D. (2007, November). Health disparities in HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis: Issues, burden, and response. A retrospective review, 2000–2004. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/nchhstp/healthdisparities/
   Google Scholar
• Thrasher, A. D., Earp, J. L., Golin, C. E., & Zimmer, C. R. (2008). Discrimination, distrust, and racial/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 49, 84–93.10.1097/QAI.0b013e3181845589
   PubMed Web of Science ®Google Scholar
• Ulett, K. B., Willig, J. H., Lin, H., Routman, J. S., Abroms, S., Allison, J., … Mugavero, M. J. (2009). The therapeutic implications of timely linkage and early retention in HIV care. AIDS Patient Care and STDs, 23, 41–49.10.1089/apc.2008.0132
   PubMed Web of Science ®Google Scholar
• Watt, M. H., Maman, S., Earp, J. A., Eng, E., Setel, P. W., Golin, C. E., & Jacobson, M. (2009). “It’s all the time in my mind”: Facilitators of adherence to antiretroviral therapy in a Tanzanian setting. Social Science & Medicine, 68, 1793–1800.10.1016/j.socscimed.2009.02.037
   PubMed Web of Science ®Google Scholar
• Wilson, K. J., Doxanakis, A., & Fairley, C. K. (2004). Predictors of non-adherence to antiretroviral therapy. Sexual Health, 1, 251–257.10.1071/SH04020
   PubMedGoogle Scholar